Insider trades
Derek J. Maetzold, Chief Officer of Castle Biosciences CSTL, has filed 0 purchases and 704 sales on the open market. Over the past 12 months that comes to a net sale of $6.7M. The latest trade was on 09/21.
Derek J. Maetzold
Pres. & Chief Exec. Officer
- Company
- Castle Biosciences CSTL
- First filing
- 23/03/16
- Trades
- 771 trades
- Buys / sales
- 0 / 704
- 12-month net buying
- −$6.7M
- Last trade
- 09/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 09/21 | 09/23 | 14,496 sh3 trades | $35.33avg. | $512,201.66 | No record | |
| Open-market sale10b5-1 plan | 06/15 | 06/17 | 4,172 sh7 trades | $20.66avg. | $86,193.52 | No record | |
| Open-market sale10b5-1 plan | 06/01 | 06/03 | 9,836 sh7 trades | $20.86avg. | $205,178.96 | No record | |
| Open-market sale10b5-1 plan | 05/20–05/21 | 05/22 | 4,172 sh14 trades | $20.15avg. | $84,076.6 | No record | |
| Open-market sale10b5-1 plan | 05/07 | 05/11 | 9,836 sh14 trades | $22.15avg. | $217,911.24 | No record | |
| Open-market sale10b5-1 plan | 04/21 | 04/23 | 4,172 sh7 trades | $25.10avg. | $104,717.2 | No record | |
| Open-market sale10b5-1 plan | 04/06 | 04/08 | 9,836 sh7 trades | $25.03avg. | $246,195.08 | No record | |
| Open-market sale10b5-1 plan | 03/26 | 03/30 | 4,172 sh7 trades | $25.55avg. | $106,594.6 | No record | |
| Open-market sale10b5-1 plan | 03/17–03/18 | 03/19 | 19,300 sh2 trades | $25.91avg. | $500,098 | −47.3% | |
| Open-market sale10b5-1 plan | 03/13–03/16 | 03/17 | 30,779 sh3 trades | $25.74avg. | $792,379.52 | −43.0% | |
| Open-market sale10b5-1 plan | 03/11–03/12 | 03/13 | 44,125 sh8 trades | $25.67avg. | $1,132,865.18 | No record | |
| Open-market sale10b5-1 plan | 02/03–02/04 | 02/05 | 4,017 sh3 trades | $39.52avg. | $158,746.03 | −4.6% | |
| Open-market sale10b5-1 plan | 01/20 | 01/22 | 4,017 sh | $40.01 | $160,720.17 | −4.4% | |
| Open-market sale10b5-1 plan | 01/05–01/06 | 01/07 | 4,017 sh2 trades | $38.76avg. | $155,698.92 | −12.0% | |
| Open-market sale10b5-1 plan | 25/12/22 | 25/12/29 | 830 sh | $40.35 | $33,490.5 | −2.4% | |
| Open-market sale10b5-1 plan | 25/12/17 | 25/12/19 | 509 sh | $40.04 | $20,380.36 | −1.5% | |
| Open-market sale10b5-1 plan | 25/12/15–25/12/16 | 25/12/17 | 32,346 sh3 trades | $38.69avg. | $1,251,399.9 | −48.1% | |
| Open-market sale10b5-1 plan | 25/12/04 | 25/12/08 | 1,339 sh | $40.03 | $53,600.17 | −3.4% | |
| Open-market sale10b5-1 plan | 25/12/02 | 25/12/04 | 2,678 sh | $39.23 | $105,057.94 | −6.4% | |
| Open-market sale10b5-1 plan | 25/11/26 | 25/12/01 | 4,258 sh | $40.09 | $170,703.22 | −9.3% |
